Niveau de preuve du suivi thérapeutique pharmacologique de la ceftriaxone
Therapie, 67 2 (2012) 145-149
Published online: 2012-08-02
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Liver function, quantified by the LiMAx test, as a predictor for the clinical outcome of critically ill patients treated with linezolid
Rawan Alraish, Sebastian G. Wicha, Otto R. Frey, Anka C. Roehr, Johann Pratschke, Martin Stockmann, Tilo Wuensch and Magnus KaffarnikTechnology and Health Care 30 (2) 309 (2022)
https://doi.org/10.3233/THC-191847
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study
Paul Le Turnier, Dominique Navas, Denis Garot, et al.Journal of Antimicrobial Chemotherapy 74 (4) 1078 (2019)
https://doi.org/10.1093/jac/dky553
Prolonged ceftriaxone‐induced immune thrombocytopenia due to impaired drug clearance: a case report
Cyril Jacquot, Morvarid Moayeri, Benjamin Kim, Sarah Shugarts, Kara L. Lynch and Andrew D. LeavittTransfusion 53 (11) 2715 (2013)
https://doi.org/10.1111/trf.12138
Antibiotic Resistance of Gram-Negative Bacilli Isolated from Pediatric Patients with Nosocomial Bloodstream Infections in a Mexican Tertiary Care Hospital
Miguel Ángel Ares, Maria Dolores Alcántar-Curiel, César Jiménez-Galicia, Nora Rios-Sarabia, Sabino Pacheco and Miguel Ángel De la CruzChemotherapy 59 (5) 361 (2013)
https://doi.org/10.1159/000362085